NFKB1 and neoplasm: In vivo data from mouse and rat models showed that resveratrol treatment decreased breast tumor initiation and onset, tumor growth and angiogenesis, likely through the inhibition of oxidative DNA damage, tumor-promoting enzymes and/or NF-κB signaling [168,195,196,197,198,199].